VERTIGIS
14.9.2023 09:01:33 CEST | Business Wire | Press release
VertiGIS, a leading global provider of spatial asset management solutions is pleased to announce the global launch of its VertiGIS Networks product line following its North American debut in May. Using purpose-built VertiGIS Networks solutions, utilities can visualize, edit and integrate their network data using modern web applications.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230912866940/en/
A fully web-based solution enables comprehensive management of all network infrastructure.
Esri, the global leader in geographic information system (GIS) software, launched the ArcGIS Utility Network in 2018. VertiGIS Networks is a state-of-the-art product line — built from the ground up — that allows utilities to visualize, trace, analyze, and edit their ArcGIS Utility Network data in both web browsers and native apps with online and offline workflows.
VertiGIS Networks can leverage the scalability and flexibility of cloud infrastructure to provide organizations with seamless integration, efficient resource utilization and increased resilience. In particular, VertiGIS Networks can automate data exchange and synchronization between GIS and SAP or other enterprise systems. This avoids duplicate data entry in different systems while ensuring high quality and integrity in the respective databases.
"VertiGIS Networks allows us to provide companies with a comprehensive solution for the entire lifecycle of their assets from design, construction and commissioning to maintenance, repair and renewal across all lines of business,″ says Drew Millen, CTO at VertiGIS. “By offering these solutions in the cloud, we are lowering the barrier to entry so that utilities can take advantage of the power provided by Esri’s ArcGIS Utility Network without the hardware infrastructure investment.”
The VertiGIS Networks product line includes VertiGIS Network Explorer, VertiGIS Network Simulator, VertiGIS Network Editor, VertiGIS Network Locator, VertiGIS Outage Manager, and VertiGIS Network Maintenance. VertiGIS data models based on the ArcGIS Utility Network can be easily customized to accommodate internal business requirements while adhering to established standards. These models ensure consistency for all lines of business and form a solid foundation for the digital twin of network infrastructure.
About VertiGIS
VertiGIS is a leading asset management and geographic information systems (GIS) solution provider and software developer. Their focus is on the development of software solutions and services that enable professionals in the utilities, government, telecommunications and infrastructure market segments to connect their business processes with spatial management technology. Used by more than 5,000 customers and millions of end users around the world, VertiGIS’ product portfolio is designed to enhance the capabilities of leading GIS software, especially Esri’s ArcGIS®. For more information visit vertigis.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230912866940/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Biocytogen Launches AI-Powered RenSuper™ Platform and Industry-First Fully Automated Antibody Discovery Infrastructure26.5.2026 14:00:00 CEST | Press release
Biocytogen today announced the launch of RenSuper Workstation, a next-generation AI-powered antibody discovery platform providing off-the-shelf access to a large-scale, experimentally validated library of fully human therapeutic antibody sequences, together with the RenSuper High-Throughput Antibody Manufacturing Automation Center, a fully automated infrastructure designed to accelerate antibody validation and production. Built on Biocytogen’s proprietary RenMice® platforms, RenSuper establishes a closed-loop antibody discovery engine combining in vivo immune repertoires, AI-driven candidate selection, automated experimental validation, and scalable manufacturing infrastructure. The platform supports the discovery and development of monoclonal antibodies, bispecifics, multispecifics, antibody-drug conjugates (ADCs), VHHs, and other advanced therapeutic modalities, significantly reducing the time and risk associated with antibody discovery. RenSuper Workstation: AI-Powered One-Click Tar
ViaLase Announces Global Commercial Introduction of the FLIGHT Procedure26.5.2026 14:00:00 CEST | Press release
First commercial femtosecond laser image-guided, high precision trabeculotomy (FLIGHT) treatments mark a new era in interventional glaucoma; one where precision, safety, and the patient experience define the new standard of care ViaLase, Inc., a commercial stage medical technology company pioneering incision-free, laser-based solutions for glaucoma, today announced the successful completion of the first commercial FLIGHT procedures performed at Centre for Sight in London by Sheraz Daya, MD, and Gus Gazzard, MD, and at Breyer, Kaymak & Klabe Augenchirurgie in Düsseldorf, Germany, by Karsten Klabe, MD. The first commercial FLIGHT procedures were performed using the ViaLuxe® Laser System to deliver an incision-free, image-guided femtosecond laser treatment designed to create precise channels through the trabecular meshwork to restore aqueous outflow and reduce intraocular pressure in patients with open-angle glaucoma. “Centre for Sight has always been committed to bringing meaningful inno
BioIVT to Spotlight ADME-Tox Expertise and Solutions at Summer 2026 Events26.5.2026 14:00:00 CEST | Press release
Company will demonstrate how high-quality, well-characterized biospecimens are critical to the success of both new approach methodologies (NAMs) and traditional studies BioIVT, the leading biospecimen solutions provider and global research partner for drug and diagnostic development, today announced it will showcase its broad portfolio of ADME-Tox solutions and research expertise at several leading industry events, including the 2026 MPS World Summit and the ISSX 16th European Meeting. The MPS World Summit takes place May 26-May 29, 2026, in Washington, D.C. BioIVT colleagues will be available at booth #115 to discuss research questions and needs, including preparation, handling, and utilization of the high-quality tissues and cells needed for microphysiological systems (MPS), as well as conducting ADME studies and bioanalysis. BioIVT offers an extensive range of control and disease state biospecimens, including SPHEROID CERTIFIED™ Hepatocytes as well as advanced HEPATOPAC® co-cultures
IHS Towers Publishes 2025 Sustainability Report26.5.2026 12:34:00 CEST | Press release
IHS Holding Limited (NYSE: IHS) (“IHS Towers”) group, one of the largest independent owners, operators, and developers of shared communications infrastructure in the world by tower count, has today published its 2025 Sustainability Report. The report covers sustainability activities from January 1, 2025 to December 31, 2025 and demonstrates IHS Towers’ continued commitment to its stakeholders, including, but not limited to, its employees, customers, suppliers, local communities, regulators, governments and shareholders. IHS Towers’ vision is to help create a connected world, where mobile connectivity promotes continued economic growth and social development. The communications infrastructure it provides is vital to enabling that connectivity. In 2025, IHS Towers continued to advance its four-pillar sustainability strategy – focusing on ethics and governance, environment and climate change, education and economic growth, our people and communities – as detailed in this report. Sam Darwi
Compass Pathways to Participate in Jefferies Global Healthcare Conference on June 3, 202626.5.2026 12:30:00 CEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will attend the Jefferies Global Healthcare Conference on June 3, 2026 and will participate in a fireside chat at 12:45pm ET. A live audio webcast of this event will be accessible from the “Events” page of the Investors section of the Compass website. A replay of the webcast will be accessible for 30 days following each event. About Compass Pathways Compass Pathways plc (Nasdaq: CMPS) is a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. We are motivated by the need to find better ways to help and empower people with serious mental health conditions who are not helped by existing treatments. We are pioneering a new paradigm for treating mental health conditions focused on rapid and durable responses through the development of our investigational CO
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom